New England Research & Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-735
Closed -$217K 140
2026
Q1
$217K Hold
735
0.09% 140
2025
Q4
$201K Sell
735
-515
-41% -$140K 0.09% 142
2025
Q3
$338K Buy
1,250
+25
+2% +$6.8K 0.16% 128
2025
Q2
$338K Buy
+1,225
New +$333K 0.16% 125
2024
Q4
Sell
-2,175
Closed -$480K 151
2024
Q3
$480K Sell
2,175
-900
-29% -$186K 0.23% 111
2024
Q2
$605K Buy
+3,075
New +$635K 0.29% 106
2023
Q1
Sell
-6,275
Closed -$1.05M 147
2022
Q4
$1.05M Buy
6,275
+4,800
+325% +$834K 0.61% 61
2022
Q3
$261K Buy
+1,475
New +$292K 0.16% 134
2022
Q1
Sell
-3,815
Closed -$872K 169
2021
Q4
$872K Sell
3,815
-1,485
-28% -$327K 0.42% 75
2021
Q3
$1.02M Buy
+5,300
New +$1.07M 0.54% 65
2020
Q1
Sell
-3,505
Closed -$704K 143
2019
Q4
$704K Buy
3,505
+125
+4% +$25.6K 0.47% 77
2019
Q3
$714K Buy
3,380
+2,150
+175% +$449K 0.52% 70
2019
Q2
$239K Sell
1,230
-275
-18% -$50.7K 0.16% 148
2019
Q1
$248K Buy
+1,505
New +$266K 0.17% 146
2017
Q3
Sell
-2,895
Closed -$363K 161
2017
Q2
$363K Sell
2,895
-200
-6% -$23.9K 0.27% 110
2017
Q1
$368K Buy
+3,095
New +$372K 0.28% 110

Other funds holding CME

New England Research & Management's CME Position: Q2 2026 in Review

New England Research & Management sold out of CME Group (CME) in Q2 2026, closing a stake of 735 shares — an estimated $217K sold.

New England Research & Management first reported a position in CME in Q1 2017 and held it in 16 quarters. The position peaked at $1.05M in Q4 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • New England Research & Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • New England Research & Management sold 735 CME Group shares in Q2 2026, an estimated $217K.
  • New England Research & Management first reported a position in CME Group in Q1 2017 and held it in 16 quarters.
  • New England Research & Management's CME Group position peaked at $1.05M in Q4 2022.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.